Understanding how very preterm infants respond to different treatments
Early Life Phenotyping of Very Preterm Infants
This study is looking at how different factors, like delivery methods and care practices, affect the health of very preterm babies born before 32 weeks, so we can find better ways to support their treatment and care.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10809386 on NIH RePORTER |
What this research studies
This research investigates the factors that influence how very preterm infants, born at or before 32 weeks of gestation, respond to various therapies. By examining the perinatal period, the study aims to identify specific characteristics and experiences that can help tailor treatments for these vulnerable infants. The research will analyze data related to delivery methods, maternal care practices, and the use of antibiotics to better understand their impact on infant health outcomes. Ultimately, the goal is to improve the care and treatment of very preterm infants by recognizing their unique needs.
Who could benefit from this research
Good fit: Ideal candidates for this research are very preterm infants born at or before 32 weeks of gestation.
Not a fit: Patients who are not very preterm infants or those born after 32 weeks of gestation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment strategies for very preterm infants, potentially improving their survival and long-term health outcomes.
How similar studies have performed: Previous research has shown that understanding individual responses to treatment in preterm infants can lead to improved care, indicating that this approach has potential for success.
Where this research is happening
Philadelphia, United States
- Children's Hosp of Philadelphia — Philadelphia, United States (Active)
Researchers
- Principal investigator: Mukhopadhyay, Sagori — Children's Hosp of Philadelphia
- Study coordinator: Mukhopadhyay, Sagori
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.